Good quality Vitamin Ad3e Injection - Tylosin Tartrate Injection – Jizhong
Good quality Vitamin Ad3e Injection - Tylosin Tartrate Injection – Jizhong Detail:
Tylosin Tartrate Injection
Specification:
5%,10%,20%
Description:
Tylosin, a macrolide antibiotic, is active against particularly gram-positive bacteria, some
Spirochetes (including leptospira); actinomyces, mycoplasmas (pplo), haemophilus
Pertussis, moraxella bovis and some gram-negative cocci. after parenteral administration,
Therapeutically active blood-concentrations of tylosin are reached within 2 hours.
Indications:
Infections caused by micro-organisms susceptible to tylosin, like e.g. respiratory tract
Infections in cattle, sheep and pigs, dysentery doyle in pigs, dysentery and arthritis caused
by mycoplasmas, mastitis and endometritis.
Dosage And Administration:
For intramuscular administration.
General: 2mg-5mg tylosin, per 10 kg bodyweight daily, during 3-5 days.
Contraindications:
Hypersensitivity to tylosin.
Concurrent administration with penicillins, cephalosporines, quinolones and cycloserine.
Withdrawal Times:
Meat:8 days
Milk:4 days
Warning:
Keep out of the touch of children
Storage:
Store in a dry, dark place between 8°c and 15°c.
Product detail pictures:
Related Product Guide:
Persisting in "High top quality, Prompt Delivery, Aggressive Price", now we have established long-term cooperation with customers from the two overseas and domestically and get new and aged clients' large comments for Good quality Vitamin Ad3e Injection - Tylosin Tartrate Injection – Jizhong , The product will supply to all over the world, such as: Costa Rica, Houston, Wellington, we rely on own advantages to build a mutual-benefit commerce mechanism with our cooperative partners. As a result, we've gained a global sales network reaching the Middle East, Turkey, Malaysia and Vietnamese.
By Claire from Estonia - 2017.06.19 13:51
The product manager is a very hot and professional person, we have a pleasant conversation, and finally we reached a consensus agreement.
By Joa from Chicago - 2017.11.11 11:41